| Zyprexa |
All Financial Data in US $ (mln) |
| Word Search (Top 10 - by date) |
Corcept Therapeutics Announces Second Quarter Results and Corporate and Development Update
Corcept Therapeutics
(August 12, 2010)
|
Transcept Pharmaceuticals Reports Second Quarter 2010 Financial Results
Transcept Pharmaceuticals
(August 09, 2010)
|
Lilly Reports Strong Second-Quarter 2010 Results
Eli Lilly
(July 22, 2010)
|
Euthymics Bioscience, Inc. Closes $24 Million Series A Financing and Completes Acquisition of DOV Pharmaceutical
Euthymics Bioscience
(July 22, 2010)
|
Seaside Therapeutics Appoints Leading Industry Executives to Its Board of Directors
Seaside Therapeutics
(July 20, 2010)
|
Corcept Therapeutics Announces First Quarter Results and Update on Development Programs
Corcept Therapeutics
(May 11, 2010)
|
Alkermes to Provide Update on Advancing Product Portfolio and Proprietary Platforms at R&D Day
Alkermes
(April 26, 2010)
|
Lilly Reports First-Quarter 2010 Results
Eli Lilly
(April 19, 2010)
|
Corcept Therapeutics Announces Fourth Quarter and Full Year 2009 Results and Update on Development Programs
Corcept Therapeutics
(March 25, 2010)
|
Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations
Eli Lilly
(March 17, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status (expiry date/ number), deals (upfront/ milestones), license revenues (royalties/ co-promotion) and much more.
|
| Summary Product Name Information |
|
|
| Product Sales Summary 2007/08 |
|
Annual Sales WW - Sales
|
Growth per Year (%)
|
|
Rank1 |
Generic Name
|
Therapeutic Subcategory
|
2007 |
2008
|
2008 |
| Zyprexa2 |
|
|
|
4,761 |
4,696 |
|
-1% |
|
|
Note: Shaded Cells3 |
|
|
More Product Information for EvaluatePharma® subscribersSubscribers see:
- Sales (historic and forecast to 2016 where available) listed by the reporting company or companies, including royalty, license and JV revenue where applicable
- Details of all events impacting the product
- Detailed product information, including sales forecasts listed by the reporting company or companies, indications (approved and in trial)
|
Register to access more FREE content:
- 2009 Product Sales analysis
- Download analysis into Excel
- Search 2 yrs of company press releases
|
|
|
|